A direct-acting antiviral treatment could eradicate acute hepatitis C infection in just six weeks of treatment.
Scientists have found that a direct-acting antiviral treatment may cure acute hepatitis C over a short duration of six weeks.
In a new study, researchers found that all patients with acute hepatitis C who were given the combination of the drugs sofosbuvir and ledipasvir over a duration of six weeks had undetectable hepatitis C virus (HCV) after a 12 week follow-up.
Those infected with HCV usually develop acute Hepatitis C, which spontaneously clears in 10 to 50 per cent of infected persons.
Early diagnosis of HCV infection is rare and the disease may go unnoticed until patients have already developed serious liver damage, researchers said.
Combination of sofosbuvir and ledipasvir is one possible regimen for treatment of patients with chronic HCV. Sustained virologic response (SVR) is greater than 95 per cent with a 12-week course of this treatment.
Read Full Article: Antiviral Treatment May Cure Hepatitis C In 6 Weeks